Cargando…

Development of an immune-related prognostic biomarker for triple-negative breast cancer

Purpose: Oncology studies employing digital dissection methodologies have provided some insight on the biological features of tumor microenvironment of Triple-negative breast cancer (TNBC), but molecular diagnostics rarely have therapeutic impact. We aimed to identify a novel prognostic biomarker to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Wang, Quan, Yang, Wei-Kang, Wang, Yong-Si, Zhou, Qiao, Lin, Jie, Wei, Xu-Xuan, Liang, Tian, Liu, Tongtong, Fan, Wen-Tao, Liang, Li, Xu, You-Nian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Clinical Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068007/ https://www.ncbi.nlm.nih.gov/pubmed/35481432 http://dx.doi.org/10.1080/07853890.2022.2067894

Ejemplares similares

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome
por: Munawar, Shahzeb, et al.
Publicado: (2021)

Expression of SOX10 in Triple-Negative Breast Carcinoma in Pakistan
por: Ali, Seemal, et al.
Publicado: (2022)

Mutant Phenotype p53 Immunohistochemical Expression Is Associated With Poor Prognostic Parameters and Disease-Free Survival in Triple-Negative Metaplastic Breast Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2021)

Complete Resolution of Paraneoplastic Membranous Nephropathy Following Curative Therapy of Triple-Negative Breast Cancer
por: Khan, Muhammad B, et al.
Publicado: (2021)

In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study
por: Passos, Ioannis D, et al.
Publicado: (2023)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Detection of Increased Expression of Claudin-1 in Triple-Negative Breast Cancer: Analysis and Clinical-Pathological Correlation
por: Ouban, Abderrahman, et al.
Publicado: (2023)

Deceptive Triple-Negative Breast Cancer of Intermediate Grade: A Case of Rare Microglandular Adenosis-Associated Carcinoma
por: Almahari, Sayed Ali I, et al.
Publicado: (2023)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

DJ-1 Oncogene as a Potential Diagnostic and Prognostic Biomarker for Head and Neck Cancer
por: De La Torre, Rey A, et al.
Publicado: (2023)

Characterization of DJ-1, PTEN, and p-Akt as Prognostic Biomarkers in the Progression of Oral Squamous Cell Carcinoma
por: Kerdjoudj, Mourad, et al.
Publicado: (2023)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings
por: Hashmi, Atif A, et al.
Publicado: (2023)

Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?
por: Karim, Muhammad Osman, et al.
Publicado: (2020)

Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma
por: Guan, Jian, et al.
Publicado: (2019)

Negative Appendicectomy Rate: Incidence and Predictors
por: Noureldin, Khaled, et al.
Publicado: (2022)

The Effect of Preoperative Imaging on the Negative Appendicectomy Rate
por: Dirie, Jamal, et al.
Publicado: (2023)

Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer
por: Sha, Shengnan, et al.
Publicado: (2022)

Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study
por: Chang, Chun-Chi, et al.
Publicado: (2018)

A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer
por: Zhou, Min, et al.
Publicado: (2022)

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
por: Wang, Xin, et al.
Publicado: (2021)

Primary Central Nervous System Lymphoma Presenting as Multifocal Brain Abscesses
por: Liang, Sai, et al.
Publicado: (2020)

Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study
por: Chen, Yi-Hsien, et al.
Publicado: (2012)

The Utility of Oncotype DX for Adjuvant Chemotherapy Treatment Decisions in Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, Node-negative Breast Cancer
por: Rizki, Hirah, et al.
Publicado: (2020)

Formation and Fixation of the Annulus of Zinn and Relation With Extraocular Muscles: A Plastinated Histologic Study and Its Clinical Significance
por: Ma, Chunjing, et al.
Publicado: (2022)

Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile
por: Haroon, Saroona, et al.
Publicado: (2021)

Cytological Grading of Breast Carcinomas and Its Prognostic Implications
por: Rajendran, Koshalya, et al.
Publicado: (2022)

The associations between serum biomarkers and stenosis of the coronary arteries
por: Feng, Lei, et al.
Publicado: (2016)

MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study
por: Jiang, Weihua, et al.
Publicado: (2021)

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
por: Zhu, Youzhi, et al.
Publicado: (2023)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Identification of Five Cytotoxicity-Related Genes Involved in the Progression of Triple-Negative Breast Cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Utility of Ultrasound and Mammography in Detection of Negative Axillary Nodal Metastasis in Breast Cancer
por: Khan, Anam, et al.
Publicado: (2020)

The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
por: Evcimik, Taner, et al.
Publicado: (2020)

Encapsulated Papillary Carcinoma of Breast: Clinicopathological Features and Prognostic Parameters
por: Hashmi, Atif A, et al.
Publicado: (2020)

A Retrospective Study of the Prognostic Patterns in Colorectal Cancer Patients
por: Patil, Jayaditya Devpal, et al.
Publicado: (2023)

CD38 – Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report
por: Thi Vinh Do, An, et al.
Publicado: (2022)

Risk Stratification of Chronic Myeloid Leukemia According to Different Prognostic Scores
por: Aijaz, Javeria, et al.
Publicado: (2020)

Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms
por: Popov, Hristo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2o3jinlpmvgvqgoggo46u3oqih